Literature DB >> 1081099

Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies.

R J DeHoratius, R Pillarisetty, R P Messner, N Talal.   

Abstract

Anti-RNA antibodies were found in 82% of 28 systemic lupus erythematosus (SLE) probands and in 16% of 124 of their family members. The incidence in 76 control family members was only 5%. In the SLE family members, the antibodies were found exclusively in 21% of the 94 close household contacts of the probands. The incidence of anti-native DNA (nDNA) antibodies was 68% for the SLE probands. The incidence of anti-nDNA antibodies in close household contacts of the probands was 6%, which was not significantly different from the 1% incidence found in control families. Lymphocytotoxic antibodies occurred in 57% of the SLE family members as a whole and in 68% of the close household contacts. In the SLE probands, lymphocytotoxic antibodies correlated with anti-single-stranded RNA (poly A) and anti-nDNA but not with anti-double-stranded RNA (poly A-poly U). On the other hand, lymphocytotoxic antibodies in the household contacts correlated with anti-double-stranded RNA (poly A-poly U) but not with anti-poly A or anti-nDNA. The anti-RNA antibodies were present in consanguineous household contacts but not in nonconsanguineous household contacts. These findings strengthen the hypothesis that both an environmental agent, possibly a virus, as well as the genetic response are important in the pathogenesis of SLE. Family members may therefore be a logical population in whom to search for specific antibodies to a viral agent.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081099      PMCID: PMC301977          DOI: 10.1172/JCI108190

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  Antibodies to viral and synthetic double-stranded RNA in discoid lupus erythematosus.

Authors:  R A Sylvester; M Attias; N Talal; D L Tuffanelli
Journal:  Arthritis Rheum       Date:  1973 May-Jun

Review 3.  Viruses and the connective tissue diseases.

Authors:  M Ziff
Journal:  Ann Intern Med       Date:  1971-12       Impact factor: 25.391

4.  Myxovirus antibody increases in human connective tissue disease.

Authors:  P E Phillips; C L Christian
Journal:  Science       Date:  1970-05-22       Impact factor: 47.728

5.  C-type viruses in systemic lupus erythematosus.

Authors:  R M Lewis; W Tannenberg; C Smith; R S Schwartz
Journal:  Nature       Date:  1974-11-01       Impact factor: 49.962

Review 6.  Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity.

Authors:  A C Allison; A M Denman; R D Barnes
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

7.  Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus.

Authors:  N Talal
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

8.  Antibodies to polynucleotides: distribution in human serums.

Authors:  D Koffler; R I Carr; V Agnello; T Fiezi; H G Kunkel
Journal:  Science       Date:  1969-12-26       Impact factor: 47.728

9.  Canine systemic lupus erythematosus. Transmission of serologic abnormalities by cell-free filtrates.

Authors:  R M Lewis; J André-Schwartz; G S Harris; M S Hirsch; P H Black; R S Schwartz
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

10.  Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy.

Authors:  R C Mellors; C Y Huang
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

View more
  19 in total

1.  Evidence that autoimmunity in man is a Mendelian dominant trait.

Authors:  W B Bias; J D Reveille; T H Beaty; D A Meyers; F C Arnett
Journal:  Am J Hum Genet       Date:  1986-11       Impact factor: 11.025

2.  Monoclonal anti-poly(rA) hybridoma antibodies from an autoimmune MRL/MpJ-lpr/lpr mouse.

Authors:  H Dang; M Fischbach; M Erdos; N Talal
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

Review 3.  Origins of anti-DNA autoantibodies.

Authors:  R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.

Authors:  P J Maddison; R P Skinner; R S Pereira; C M Black; B M Ansell; M I Jayson; N R Rowell; K I Welsh
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

5.  Lymphocytotoxins in epileptic patients receiving phenytoin.

Authors:  B S Ooi; K S Kant; I B Hanenson; A J Pesce; V E Pollak
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

Review 6.  Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.

Authors:  Stefanie Gerstberger; Markus Hafner; Manuel Ascano; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Antiidiotypic antibodies against anti-DNA antibodies in sera of families of lupus patients.

Authors:  N I Abdou; R Suenaga; M Hatfield; M Evans; K M Hassanein
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

8.  Anti-idiotypic antibody against anti-DNA in sera of laboratory personnel exposed to lupus sera or nucleic acids.

Authors:  M Hatfield; M Evans; R Suenaga; K M Hassanein; N I Abdou
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

9.  Segregation of lymphocyte low-molecular-weight DNA and antinuclear-antibodies in a family with systemic lupus erythematosus in first cousins.

Authors:  H Levcovitz; M A Fletcher; P Phillips; H A Chertok; R Altman; P J Benke
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

10.  Inherited deficiency of the second component of complement. Rheumatic disease associations.

Authors:  D Glass; D Raum; D Gibson; J S Stillman; P H Schur
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.